Article
Skull Base Osteomyelitis - Value of Hyperbaric Oxygen Therapy
Search Medline for
Authors
Published: | July 8, 2008 |
---|
Outline
Text
Objectives: This study reports on the value of adjuvant hyperbaric oxygen therapy (HBO) with respect to the functional outcome in skull base osteomyelitis (SBO). Furthermore diagnostic signs especially on imaging are elaborated.
Methods: The retrospective study included all cases of SBO treated between July 2002 and November 2006. Clinical data, microbiology, laboratory and radiological findings were reviewed. Treatment modality data were analysed. The outcome with regard to neurological or functional deficit was assessed and the value of adjuvant HBO therapy was evaluated.
Results: Ten patients with SBO could be selected. The presumption diagnosis based on CT and/or MRI in first line. Treatment included high dose antibiotics, surgical debridement and adjuvant HBO therapy. Cure rate of treated patients was 8/8, regarding inflammatory signs. Two patients refused any further therapy during the course, in both the outcome was fatal. Functional recovery of cranial nerve deficits could be reached in 6/8. Two patients had residual cranial nerve palsies. The outcome was mainly influenced by the treatment modality and duration of cranial nerve involvement.
Conclusions: Adjuvant hyperbaric oxygen therapy has been proved to be highly effective in the treatment of advanced SBO. Cranial nerve palsies can recover completely under optimized treatment including adjuvant HBO therapy.